Lechleiter puts reorganization stamp on Lilly

May 21, 2008
In his second month as president of Eli Lilly and Co., John Lechleiter has ordered a reorganization to streamline the Indianapolis pharmaceutical maker.

The changes will eliminate management layers and clarify roles and responsibilities in order to speed decision-making, Lechleiter said in a statement.

Lilly spokesman Phil Belt the reorganization will result in few, if any, layoffs.

The reorganization stretches across several units.

-Lilly Research Laboratories is being restructured to combine global regulatory, medical and patient safety information.

-Within International Operations, European operations has been boiled down from four to two areas of responsibility: European mid-size, and central and eastern Europe; and Africa, Middle East and Commonwealth of Independent States, which are 10 countries formerly within the Soviet bloc.

-U.S. operations will shrink from four division vice president positions to two focusing on physicians and institutions, such as hospitals and third-party payers.

-Global marketing and sales also is streamlining operations.

Lechleiter replaced Sidney Taurel, who retired, on April 1.

Lilly shares fell 2 cents this morning to trade at $48.94.

Source: XMLFULL/XMLFull15052.xml

Recent Articles by Norm Heikens

Comments powered by Disqus